Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preventing preterm birth with cervical length screening and progesterone in healthy singleton pregnancies
2008-005987-15Phase 3Active
- Sponsor
- AMC Health
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of progesterone in preterm birth (2 arms), sponsored by AMC Health. Primary endpoint: Composite bad neonatal condition at 10 weeks corrected age. Started Oct 2008; status: active.
02
Drugs
progesterone
03
Conditions
preterm birth
Beyond the preview
Go deeper on 2008-005987-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005987-15.